{
  "docId": "019dd923-622c-750b-8b9a-06a86cfc80f7",
  "docSlug": "aa98098de0fa",
  "documentTitle": "Quintis Limited (QIN)",
  "authorId": "57_Viceroy_Research",
  "authorName": "Viceroy Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.70709807,
  "pageNumber": 32,
  "pageCount": 49,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide uses a direct quote from an FDA warning letter to undermine the credibility of the partner company.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-06a86cfc80f7/32",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-06a86cfc80f7",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-06a86cfc80f7.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-06a86cfc80f7#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.72
      },
      "kind": "callout",
      "text": "Why is TFS associating with a company which facilitated fraudulent and potentially dangerous advertising statements?\n\nDoes new management have any transparency in the company’s sales channels?",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88eeede8-d7c3-4217-bb66-e6bda51286fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Why is TFS associating with a company which facilitated fraudulent and potentially dangerous advertising statements?",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-25b3-7229-bee8-a031b5ff8471",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.76,
        "x": 0.12,
        "y": 0.54
      },
      "kind": "paragraph",
      "text": "TFS has made no comments regarding Young Living’s interactions with the FDA, whether their products are safe for ingestion or if they possess any medicinal or magical capability.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cc44e33-8526-42a8-8d9a-135ef9c10ca6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.76,
        "x": 0.12,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "We would advise our readers to look over the FDA warning in full, especially the section titled “Young Living Versus Ebola Virus” to fully understand the claims regularly made by Young Living “consultants” and for a laugh (the FDA has a sense of humor!).",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4759a887-0739-4a77-b406-f86cae01a67c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.76,
        "x": 0.12,
        "y": 0.29
      },
      "kind": "paragraph",
      "text": "These “consultants” are ostensibly Young Living salespeople attempting to drum up business. This FDA warning was in response to several articles claiming that ingesting essential oils would either heal or lessen the effect of serious medical conditions, most notably Ebola. Not only misleading, but dangerous given the track record of other ingested essential oils in the past. This stern reprimand causes us to question whether Young Living’s existence as an alleged supply avenue is appropriate given TFS’s planned involvement in pharmaceuticals.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71530418-f7e9-49e6-8433-752e4bc36905",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.76,
        "x": 0.12,
        "y": 0.67
      },
      "kind": "paragraph",
      "text": "Fun fact: the term ‘Essential’ when conjoined with ‘Oil’, is derived from the word ‘Essence’. Therefore, it might smell nice, but you don’t need it.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ab9f1d3-4f92-4c11-84c6-bbbc1e534da2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "TFS recently announced an agreement with Young Living to supply Indian Sandalwood oil at a price of US$4,500/kg with fixed annual increases of 2.5%. Young Living is a multi-level-marketing scheme offering essential oils and facilitating blatant lies as evidenced by the FDA's scathing letter warning:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d94a89c6-4abb-4198-b3af-d57a42820049",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "TFS’s subsidiary Santalis Pharmaceuticals Inc. is reportedly in the process of obtaining FDA approval for pharmaceutical grade sandalwood oil. We cannot imagine the FDA being content with TFS’s involvement with Young Living, a company tarnishing the reputation of legitimate pharmaceutical companies.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9a70d61-96cc-4028-93bd-2ee05612f35b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.7,
        "x": 0.15,
        "y": 0.17
      },
      "kind": "quote",
      "text": "Your consultants promote many of your Young Living Essential Oil Products for conditions such as, but not limited to, viral infections (including Ebola), Parkinson's disease, autism, diabetes, hypertension, cancer, insomnia, heart disease, post-traumatic stress disorder (PTSD), dementia, and multiple sclerosis, that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners.",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78632e40-4bae-45fc-9938-503494a084cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Your consultants promote many of your Young Living Essential Oil Products for conditions such as, but not limited to, viral infections (including Ebola), Parkinson's disease, autism, diabetes, hypertension, cancer, insomnia, heart disease, post-traumatic stress disorder (PTSD), dementia, and multiple sclerosis, that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners.\" — FDA",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-25b3-7229-bee8-a5655baa6a85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.76,
        "x": 0.12,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "39 http://www.tflstd.com.au/files/5014/7277/8698/Supply Agreement With Worlds Leading Essential Oil Company.pdf\n40 http://youngliving.cdn.cymbeo.com/f/69rwmp3g/126c69rvgm8k/Compensation-Plan-Highlights_1.pdf\n41 http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2014/ucm416023.htm\n42 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546250/",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9a536bc-f562-4ead-aa5b-6384f81ecf02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.12,
        "y": 0.09
      },
      "kind": "title",
      "text": "The Young Living Agreement",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d7adf4c-ef69-4658-b69e-9cc14e748b01",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 47,
      "from": 9,
      "beatId": "93a773a6-3186-4f1f-8643-15095fd13522",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "Repeatedly highlighting contradictions and inconsistencies in Quintis Limited's reporting and practices.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}